| Cancer | ID | Symbol | Immune Pathway | P value | FDR value | ES value | Score | number |
|---|---|---|---|---|---|---|---|---|
| ACC | ENSG00000163563 | MNDA | Antimicrobials | 1.901e-03 | 1.572e-02 | 0.3296 | 0.9962 | 90 |
| ACC | ENSG00000163563 | MNDA | TCR signaling Pathway | 1.965e-03 | 1.572e-02 | 0.5415 | 0.9961 | 23 |
| ACC | ENSG00000166886 | NAB2 | Antigen Processing and Presentation | 1.942e-03 | 3.107e-02 | -0.4877 | -0.9961 | 34 |
| ACC | ENSG00000205531 | NAP1L4 | Cytokine Receptors | 1.332e-03 | 2.130e-02 | -0.3596 | -0.9973 | 79 |
| ACC | ENSG00000204301 | NOTCH4 | Cytokine Receptors | 1.056e-03 | 1.690e-02 | 0.4392 | 0.9979 | 41 |
| ACC | ENSG00000177425 | PAWR | TCR signaling Pathway | 1.623e-03 | 2.597e-02 | 0.5655 | 0.9968 | 24 |
| ACC | ENSG00000166228 | PCBD1 | Antigen Processing and Presentation | 1.397e-03 | 1.117e-02 | 0.4842 | 0.9972 | 33 |
| ACC | ENSG00000166228 | PCBD1 | Natural Killer Cell Cytotoxicity | 1.397e-03 | 1.117e-02 | 0.5311 | 0.9972 | 30 |
| ACC | ENSG00000197724 | PHF2 | Antigen Processing and Presentation | 1.595e-03 | 2.552e-02 | -0.5349 | -0.9968 | 37 |
| ACC | ENSG00000140464 | PML | Antigen Processing and Presentation | 1.626e-03 | 1.301e-02 | 0.5673 | 0.9967 | 45 |
| ACC | ENSG00000140464 | PML | Antimicrobials | 1.460e-03 | 1.301e-02 | 0.3916 | 0.9971 | 80 |
| ACC | ENSG00000177700 | POLR2L | TCR signaling Pathway | 1.901e-03 | 3.042e-02 | -0.4689 | -0.9962 | 20 |
| ACC | ENSG00000102054 | RBBP7 | Antigen Processing and Presentation | 1.294e-03 | 1.035e-02 | 0.515 | 0.9974 | 45 |